Sign in
4

Changes in Ownership

ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-22-023742

Options or other derivatives

  • EVP, COO, Head of Commercial acquired 89,062 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Teehan Brendan EVP, COO, Head of Commercial 2022-04-05 Grant or award · Stock Options (Right to Buy) +68,966 68,966 D
Teehan Brendan EVP, COO, Head of Commercial 2022-04-05 Grant or award · Restricted Stock Units +20,096 20,096 D
Loading xslF345X03/doc4.xml…